Generated by GPT-5-mini| Fudan University Shanghai Cancer Center | |
|---|---|
| Name | Fudan University Shanghai Cancer Center |
| Native name | 复旦大学附属肿瘤医院 |
| Established | 1931 |
| Type | Public teaching hospital |
| Affiliation | Fudan University |
| Location | Shanghai |
| Country | China |
Fudan University Shanghai Cancer Center is a major oncology hospital and research institute affiliated with Fudan University in Shanghai, China, serving as a national referral center for cancer diagnosis and treatment. The center operates comprehensive clinical, research, and education programs that interact with institutions such as Peking University Cancer Hospital, Zhejiang University School of Medicine, Shanghai Jiao Tong University School of Medicine, Chinese Academy of Sciences and international partners including University of Cambridge, Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center and Mayo Clinic.
The center traces origins to early 20th-century medical reforms in Shanghai and was shaped by collaborations with institutions like St Thomas' Hospital and the Red Cross Society of China, reflecting influences from figures associated with Sun Yat-sen and developments after the Xinhai Revolution. Throughout the 20th century the institution evolved alongside milestones such as the establishment of Fudan University medical faculties, interactions with Peking Union Medical College, and national public health initiatives tied to campaigns like the Patriotic Health Campaign. In late 20th and early 21st centuries the center expanded amid China's healthcare modernization, engaging with projects connected to National Natural Science Foundation of China, Ministry of Science and Technology (China), and multinational clinical trial consortia involving partners such as University of Oxford and Harvard Medical School.
Administration is integrated with Fudan University governance structures and interfaces with municipal bodies in Shanghai Municipal People's Government, linking to regulatory frameworks like the National Health Commission (China). Leadership teams include roles that liaise with academicians of the Chinese Academy of Engineering and Chinese Academy of Sciences, and collaborative committees coordinate with centers such as Shanghai Institutes for Biological Sciences and departments at Zhongshan Hospital. Governance incorporates clinical governance models used by Johns Hopkins Hospital and strategic research units patterned after institutes such as Institut Gustave Roussy.
The center's main campus in Yangpu District houses inpatient wards, outpatient clinics, and specialized units mirroring layouts found at Royal Marsden Hospital and Peter MacCallum Cancer Centre, with satellite campuses and affiliated hospitals across Minhang District and partnerships at sites like Shanghai Sixth People's Hospital and Shanghai Cancer Center (Shanghai Medical College). Facilities include advanced radiotherapy suites with technologies comparable to those at European Organization for Nuclear Research collaborations, molecular pathology platforms linked to Cold Spring Harbor Laboratory methodologies, and biobanks coordinated with networks such as International Cancer Genome Consortium and The Cancer Genome Atlas.
Clinical services cover multidisciplinary oncology specialties including thoracic oncology similar to programs at National Cancer Center Hospital (Japan), hepatobiliary oncology paralleling Asan Medical Center, gastrointestinal oncology modeled on MD Anderson Cancer Center protocols, breast oncology aligned with Royal Marsden Hospital practices, and hematologic oncology reflecting collaborations with Fred Hutchinson Cancer Center. Subspecialties include medical oncology, surgical oncology, radiation oncology, pediatric oncology, and palliative care coordinated with concepts used by St Jude Children's Research Hospital, MD Anderson Proton Therapy Center, and clinical trial frameworks of European Organisation for Research and Treatment of Cancer.
Research programs span translational oncology, molecular epidemiology, immuno-oncology, and precision medicine, interfacing with consortia such as International Agency for Research on Cancer, Global Burden of Disease, Human Genome Project legacies, and collaborations with Broad Institute scientists. The center participates in clinical trials registered with networks akin to ClinicalTrials.gov and undertakes basic research in tandem with groups at ShanghaiTech University, Tsinghua University biomedical engineering programs, and the National Center for Protein Sciences. Research outputs align with publication venues like Nature, The Lancet Oncology, Journal of Clinical Oncology, and Cell.
As a teaching hospital affiliated with Fudan University medical schools, the center provides undergraduate, graduate, and residency training modeled on curricula analogous to Royal College of Physicians frameworks and postgraduate programs comparable to those at Harvard Medical School and University of California, San Francisco. Training includes specialty fellowships, doctoral supervision linked to Chinese Academy of Medical Sciences traditions, and continuing medical education programs coordinated with organizations such as World Health Organization regional offices and international exchange agreements with European School of Oncology.
The center has received national recognition in rankings compiled by organizations akin to ShanghaiRanking Consultancy and participates in award programs like national science awards related to National Science and Technology Awards and honors associated with academicians of the Chinese Academy of Sciences. International collaborations encompass partnerships with Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center, University of Oxford, University of Tokyo, Karolinska Institutet, and networks such as the Asian Oncology Summit, strengthening its role in multinational research consortia, clinical guideline development, and capacity-building initiatives.
Category:Hospitals in Shanghai Category:Oncology organizations Category:Fudan University